vitamin-k-semiquinone-radical and Birth-Weight

Topics: Anemia, Hypochromic; Ascorbic Acid; Avitaminosis; Birth Weight; Female; Folic Acid; Humans; Infant, Newborn; Infant, Premature, Diseases; Iron; Pregnancy; Time Factors; Vitamin A; Vitamin D; Vitamin E; Vitamin K; Vitamins

Topics: Ascorbic Acid; Birth Weight; Body Height; Body Weight; Calcium, Dietary; Diet; Dietary Carbohydrates; Dietary Fats; Dietary Proteins; Eclampsia; Energy Transfer; Female; Germany, West; Humans; Lactation; Maternal Mortality; Nutritional Physiological Phenomena; Obesity; Obstetric Labor, Premature; Pre-Eclampsia; Pregnancy; Prenatal Care; Vitamin A; Vitamin B Complex; Vitamin D; Vitamin E; Vitamin K

Recommendations for vitamin K supplementation were recently changed to 3 x 1 mg orally in healthy term neonates and 0.2 mg parenterally in prematures and high-risk neonates. Prothrombin times (PT) at reduced vitamin K doses (120 patients, 170 samples) during the first 6 weeks of life were below 40% in 6 patients only; all low PTs were unrelated to vitamin K. In the remaining patients, median PT was 100%; 79% of patients had values above 70%. PT was related to birthweight, gestational age and age. There was no decrease over the observation period. Following reduced oral and parenteral vitamin K regimens PTs were well within published reference values for neonates given larger amounts of vitamin K.

Topics: Administration, Oral; Age Factors; Birth Weight; Gestational Age; Hemostatics; Humans; Infant, Newborn; Infant, Premature; Injections, Intramuscular; Prospective Studies; Prothrombin Time; Reference Values; Vitamin K

Topics: Administration, Oral; Biomarkers; Birth Weight; Breast Feeding; Female; Follow-Up Studies; Gestational Age; Humans; Infant, Newborn; Injections, Intramuscular; Male; Pilot Projects; Protein Precursors; Prothrombin; Prothrombin Time; Vitamin K; Vitamin K Deficiency

We conducted a prospective study to determine (1) the maternal-fetal vitamin K1 transport in premature infants after vitamin K1 was given to the mothers antenatally and (2) the vitamin K1 effects on blood coagulation in the babies. Women in labor at less than or equal to 34 weeks of gestation were randomly selected to receive antenatal vitamin K1, 5 mg given intramuscularly (vitamin K1 group), or no vitamin K1 (control group). Eight infants, including one set of twins, were in the vitamin K1 group and six in the control group. Vitamin K1 concentrations were higher in the vitamin K1 group than in the control group (p = 0.06). Activated partial thromboplastin time was prolonged, and factor II coagulation activity and factor II antigen were proportionately decreased in cord plasma in both groups. The average ratio of factor II coagulation activity to antigen was not decreased in either group. Protein induced by vitamin K absence-II (PIVKA-II) was not detectable in any cord plasma sample in either group. These findings support previous reports that the decreased vitamin K-dependent coagulation activity in premature infants is the result of reduced synthesis of precursor proteins, rather than the result of vitamin K deficiency, and suggest that additional vitamin K1 is not likely to improve coagulation activity. Among those infants who underwent cranial ultrasonography, all four in the vitamin K1 group and one of five in the control group had mild intraventricular hemorrhage. Studies of a larger number of patients are necessary before it can be established that maternal antenatal administration of vitamin K1 results in improvement of coagulation and the prevention of intraventricular hemorrhage in premature infants.

Topics: Birth Weight; Blood Coagulation; Female; Fetal Blood; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Maternal-Fetal Exchange; Partial Thromboplastin Time; Pregnancy; Prospective Studies; Prothrombin Time; Vitamin K

Fat-soluble vitamins, including vitamins A, D and E, play an important role in the regulation of glucose and lipid metabolism, and may affect infant birth weight. Evidence on the association of birthweight with fat-soluble vitamins is controversial. Therefore, this study aims is to determine the associations of birthweight with vitamin A, D, and E concentrations in cord blood.. A total of 199 mother-infant pairs were enrolled in the study. According to gestational age and birth weight, the mother-infant pairs were divided into small for gestational age (SGA), appropriate for gestational age (AGA), and large for gestational age (LGA). The Vitamin A, D, and E concentrations in serum were measured by high-performance liquid chromatography tandem-mass spectrometry.. The concentrations of vitamin A in the SGA group were significantly lower than those in the AGA and LGA groups. The concentrations of vitamin E in the SGA group were significantly higher than those in the AGA and LGA groups. However, no significant differences were observed in vitamin D among the three groups. Being male (β = 0.317, p < 0.001) and birth weight (β = 0.229, p = 0.014) were positively correlated with the levels of vitamin A. Birth weight (β = -0.213, p= 0.026) was correlated with lower levels of vitamin E. No correlation was found between influencing Factors and the levels of vitamin D (p> 0.05). After adjusting for gestational age, sex, mother's age, delivery mode, pre-pregnancy BMI, and weight gain during pregnancy, the levels of cord blood vitamin A were positively correlated with birth weight (p=0.012).. The infant's birth weight is associated with the levels of cord blood vitamins A and E. The dysregulation of vitamins A and E in infants may be a risk factor for fetal growth and future metabolic diseases.

Topics: Birth Weight; Female; Fetal Blood; Fetal Growth Retardation; Humans; Infant; Male; Pregnancy; Vitamin A; Vitamin D; Vitamin E; Vitamin K; Vitamins

The aim of this observational cohort study was to specify the risk of the vitamin K antagonist (VKA) phenprocoumon during first trimester of pregnancy, in particular to estimate the risk of birth defects and spontaneous fetal loss. Four hundred eight pregnancies with phenprocoumon exposure were compared to 1,642 pregnancies neither exposed to VKA nor to other major teratogens or fetotoxicants. There was no typical warfarin embryopathy in our exposed cohort. However, the overall rate of major birth defects was significantly increased (7.4 % vs 2.3 %; adjusted odds ratio [OR

Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Abortion, Therapeutic; Adult; Anticoagulants; Birth Weight; Blood Coagulation; Drug Administration Schedule; Drug Substitution; Female; Humans; Infant, Newborn; Logistic Models; Odds Ratio; Phenprocoumon; Pregnancy; Pregnancy Trimester, First; Premature Birth; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Vitamin K; Young Adult

Despite administration of vitamin K (VK), some infants show lower activity of VK-dependent coagulation factors and they could develop intracranial hemorrhage. For preventing VK deficiency bleeding (VKDB) in infants, oral administration of VK and a screening test for VK deficiency are carried out in Japan. For the screening, the total activity of VK-dependent coagulation factors is measured using a commercial product, Normotest. This study was undertaken to clarify the importance of the following genetic and environmental factors on the coagulation status in one-month-old infants: two polymorphisms in the factor VII gene, -323P0/10 (a 10-bp insertion in the promoter region at position -323) and R353Q (the replacement of arginine [R] with glutamine [Q] at residue 353) and sex, age, gestational age, birth weight, and feeding regimen. Two hundred Japanese infants (34.6 +/- 4.0 days old) were screened for VK-dependent coagulation activity with Normotest and were genotyped for the two polymorphisms. Among the subjects screened, 18 infants (9%) carried the P10 allele and 26 (13%) carried the R353Q allele. Multiple regression analysis showed that the 10-bp inserted (P10) allele or the Q allele was associated with the lower coagulation activities. The coagulation activities for the R/Q genotype were significantly lower than those for the R/R genotype and those for the P0/P10 genotype were significantly lower than those for the P0/P0 genotype. Therefore, infants who carry the P10 allele or the Q allele show lower activity of VK-dependent coagulation factors. These infants may have a higher risk of VKDB manifestation.

Topics: Birth Weight; Blood Coagulation; Blood Coagulation Factors; Blood Coagulation Tests; Body Weight; Bottle Feeding; Breast Feeding; Factor VII; Female; Gene Frequency; Genotype; Gestational Age; Humans; Infant; Infant, Newborn; Male; Polymorphism, Genetic; Regression Analysis; Sex Factors; Vitamin K; Vitamin K Deficiency; Vitamin K Deficiency Bleeding

To conduct and report monitoring of vitamin K deficiency bleeding (VKDB) in Great Britain and Ireland following the 1988-90 survey (VKDB-90).. Two 2-year surveys conducted during 1993-4 (VKDB-94) and 2001-02 (VKDB-02).. Data collected from all consultant paediatricians in Great Britain and Ireland.. All infants presenting with bleeding resulting from vitamin K (VK) deficiency.. Incidence of VKDB, related mortality/morbidity and VK prophylaxis recommended/received, noting predisposing features.. Compared with previous studies, VKDB-02 found fewer cases of VKDB (RR: 0.27 (95% CI: 0.12 to 0.59), p<0.001) with no deaths, no long-term morbidity and reduced incidence among those receiving any oral dosing (RR: 0.24 (95% CI: 0.06 to 1.01), p<0.059). Breast-fed infants accounted for the vast majority of cases. The number receiving no prophylaxis fell consecutively over time: 20 of 27 in VKDB-90, 10 of 32 in VKDB-94 and 4 (because of parental refusal) of 7 in VKDB-02. Seven received one oral dose of VK in VKDB-90, 16 in VKDB-94 and none in VKDB-02. Underlying liver disease was found in six cases in VKDB-90, 12 in VKDB-94 and one in VKDB-02.. In the most recent survey, the incidence of VKDB was about one third that in the two earlier studies. Late onset VKDB remains virtually confined to breast-fed infants who have received either no VK or just one oral dose. The effectiveness of oral prophylaxis regimens has improved over the last 15 years, but parental refusal of prophylaxis has become more problematic.

Topics: Age of Onset; Antifibrinolytic Agents; Birth Weight; Breast Feeding; Health Surveys; Humans; Incidence; Infant; Infant, Newborn; Ireland; Liver Diseases; Male; Prospective Studies; Sex Distribution; United Kingdom; Vitamin K; Vitamin K Deficiency; Vitamin K Deficiency Bleeding

Vitamin K antagonists (VKA) are known to act as teratogens; however, there is still uncertainty about the relative risk for birth defects and the most sensitive period. In a multi-centre (n = 12), observational, prospective study we compared 666 pregnant women exposed to phenprocoumon (n = 280), acenocoumarol (n = 226), fluindione (n = 99), warfarin (n = 63) and phenindione (n = 2) to a non-exposed control group (n = 1,094). Data were collected by institutes collaborating in the European Network of Teratology Information Services (ENTIS) during individual risk counselling between 1988 and 2004. Main outcome measures were coumarin embryopathy and other birth defects, miscarriage rate, birth-weight, and prematurity. The rate of major birth defects after 1st trimester exposure was significantly increased (OR 3.86, 95% CI 1.86-8.00). However, there were only two coumarin embryopathies (0.6%; both phenprocoumon). Prematurity was more frequent (16.0% vs. 7.6%, OR 2.61, 95% CI 1.76-3.86), mean gestational age at delivery (37.9 vs.39.4, p<0.001), and mean birth weight of term infants (3,166 g vs. 3,411 g; p < 0.001) were lower compared to the controls. Using the methodology of survival analysis, miscarriage rate reached 42% vs. 14% (hazard ratio 3.36; 95% CI 2.28-4.93). In conclusion, use of VKA during pregnancy increases the risk of structural defects and other adverse pregnancy outcomes. The risk for coumarin embryopathy is, however, very small, in particular when therapy during the 1(st) trimester did not take place later than week 8 after the 1(st) day of the last menstrual period. Therefore, elective termination of a wanted pregnancy is not recommended if (inadvertent) exposure took place in early pregnancy. Close follow-up by the obstetrician including level II ultrasound should be recommended in any case of VKA exposure during pregnancy.

Topics: Abnormalities, Drug-Induced; Abortion, Induced; Abortion, Spontaneous; Acenocoumarol; Adverse Drug Reaction Reporting Systems; Anticoagulants; Birth Weight; Female; Fetal Diseases; Gestational Age; Humans; Phenindione; Phenprocoumon; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, First; Premature Birth; Prospective Studies; Vitamin K; Warfarin

This study was undertaken to evaluate the risks and pregnancy outcome in women with prosthetic heart valves on different anticoagulent regimens.. A retrospective chart review of 82 pregnancies in 33 women with mechanical valve prostheses at a tertiary referral center from 1987 to 2002. The main outcome measures were major maternal complications and perinatal outcome.. The valve replaced was mitral (60.6%), aortic (18.2%), and both (21.2%). Fifty-four pregnancies (65.9%) resulted in live births, 9 (11.0%) had stillbirths (all on warfarin), and 12 (14.6%) had spontaneous and 7 (8.5%) therapeutic abortions (all on warfarin). The rate of spontaneous abortion was highest in women on warfarin throughout pregnancy (P < .01). The live birth rate was higher in women on heparin compared with those on warfarin (P < .01), and in those on heparin/warfarin compared with warfarin alone (P < .01). There were no maternal deaths; however, 3 patients had mitral valve thrombosis (2 on heparin and 1 on warfarin) necessitating surgery in 1 patient and medical thrombolysis in 2 patients. Hemorrhagic complications occurred in 5 patients, 4 of whom required transfusion.. No single anticoagulant regimen confers complete protection from thromboembolic phenomena in pregnancy. Despite a high maternal morbidity rate, the perinatal outcome is acceptable when pregnancy progresses beyond the first trimester.

Topics: Abortion, Spontaneous; Abortion, Therapeutic; Birth Weight; Delivery, Obstetric; Female; Fetal Death; Fetal Growth Retardation; Gestational Age; Heart Valve Prosthesis; Heparin; Humans; Mitral Valve; Obstetric Labor, Premature; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Retrospective Studies; Thrombosis; Vitamin K; Warfarin

A medical record-based study of leukaemia and non-Hodgkin's lymphoma diagnosed before the age of 30 years was carried out at three hospitals in the south of England. Findings for 177 cases and 354 age- and sex-matched controls are presented here. For documented viral infection in pregnancy, the odds ratio (OR) was 6.0 [95% confidence interval (CI) 1.2-29.7] for leukaemia and infinity (95% CI 1.24-infinity) for non-Hodgkin's lymphoma. Mothers of leukaemic cases were more likely to be anaemic, the OR for a pregnancy haemoglobin below 10 g being 3.8 (95% CI 1.3-11.1). An association with birthweight was found for acute myeloid leukaemia, the OR for birthweights > 3500 g being 6.2 (95% CI 1.3-29.8). Further, the preceding siblings of those diagnosed with any form of leukaemia were also more likely to weigh > 3500 g at birth (OR 2.2; 95% CI 1.1-4.4). Overall, leukaemic cases appeared to be comparatively robust at birth with respect to other indicators of well-being, the ORs for jaundice, phototherapy, admission to special care nursery and neonatal intensive care all being less than 1.0. Further, no relation between childhood leukaemia and neonatal administration of intramuscular vitamin K was noted (OR 0.6, 95% CI 0.3-1.4; for acute lymphoblastic leukaemia diagnosed between the ages of 1 and 6 years).

Topics: Adolescent; Adult; Birth Weight; Case-Control Studies; Child; Child, Preschool; England; Female; Humans; Infant; Leukemia; Lymphoma, Non-Hodgkin; Maternal Age; Maternal-Fetal Exchange; Neonatology; Odds Ratio; Parity; Pregnancy; Pregnancy Complications; Vitamin K

The vitamin K coagulation status in surgical newborns, who may be at increased risk of developing hypocoagulability and hemorrhage, has not previously been studied. Therefore, we measured the combined activity of the plasma vitamin K-dependent coagulation factors (Thrombotest), total prothrombin, PIVKA II, plasma vitamin K1, fibrinogen, D-Dimer, and platelets in 49 newborns admitted to a neonatal surgical intensive care unit. All infants had significant pathology, and treatment involved surgery in all but two. Twenty-three infants (47%) underwent surgery on two or more occasions. Intravenous or oral antibiotics were used in all patients and many received more than one course. All infants had vitamin K1 prophylaxis at birth. At day 0 (date of birth), the mean Thrombotest and total prothrombin levels were 51% (range, 20% to 100%) and 40% (range, 24% to 59%), respectively. Coagulation activity decreased on day 1 (P > .1) and was followed by a graduate increase in clotting activity, reaching normal adult levels (> 60%) at day 5 for Thrombotest and day 24 for total prothrombin. Only three infants had a Thrombotest less than 20%. PIVKA II was detected in 20 cases (41%). However, levels were within normal limits (< 0.9%) in 17 of these, and between 1.0 and 4.8% in the remaining three infants. There was no relationship between elevated PIVKA levels and coagulation activity in these patients. Plasma vitamin K1 was very high, particularly in the first days of life.(ABSTRACT TRUNCATED AT 250 WORDS)

Topics: Birth Weight; Comorbidity; Congenital Abnormalities; Creatinine; England; Gestational Age; Hospitals, General; Humans; Infant, Newborn; Injections, Intramuscular; Intensive Care Units, Neonatal; Liver Function Tests; Prothrombin Time; Risk Factors; Vitamin K; Vitamin K Deficiency Bleeding

Topics: Birth Weight; Blood Coagulation Factors; Blood Coagulation Tests; Drug Evaluation; Female; Humans; Infant, Newborn; Pregnancy; Vitamin K; Vitamin K Deficiency Bleeding

Topics: Bilirubin; Birth Weight; Contusions; Female; Gestational Age; Humans; Hyperbilirubinemia; Infant, Newborn; Jaundice, Neonatal; Male; Phototherapy; Respiratory Distress Syndrome, Newborn; Temperature; Vitamin K

Topics: Asphyxia Neonatorum; Birth Weight; Blood Coagulation Tests; Blood Preservation; Cerebral Hemorrhage; Freezing; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Infusions, Parenteral; Plasma; Prothrombin Time; Vitamin K

Topics: Adult; Age Factors; Birth Weight; Blood Cell Count; Blood Platelets; Child; Factor IX; Factor V; Factor VIII; Fibrinogen; Gestational Age; Hematocrit; Humans; Infant, Newborn; Prothrombin; Vitamin K

Topics: Birth Weight; Chlorpromazine; Humans; Hypothermia, Induced; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Israel; Prednisolone; Respiratory Distress Syndrome, Newborn; Vitamin K

Topics: Bilirubin; Birth Weight; Factor V; Factor VII; Hematocrit; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Jaundice, Neonatal; Phenobarbital; Prothrombin; Vitamin K

Topics: Ascorbic Acid; Birth Weight; Breast Feeding; Gastroenteritis; Humans; Hypernatremia; Infant Food; Infant Nutrition Disorders; Infant Nutritional Physiological Phenomena; Infant, Newborn; Infant, Newborn, Diseases; Metabolism, Inborn Errors; Respiratory Tract Infections; Tetany; Vitamin A; Vitamin D; Vitamin K; Vomiting

Topics: Acid-Base Equilibrium; Asphyxia Neonatorum; Birth Weight; Blood Coagulation Tests; Blood Transfusion; Freezing; Hemorrhage; Humans; Hypoxia; Infant, Newborn; Plasma; Vitamin K

Topics: Birth Weight; Blood Coagulation; Blood Coagulation Disorders; Blood Platelets; Humans; Infant, Newborn; Infant, Newborn, Diseases; Vitamin K; Vitamin K Deficiency Bleeding

Topics: Birth Injuries; Birth Weight; Craniocerebral Trauma; Female; Hematoma; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Injections, Intramuscular; Male; Punctures; Sex Factors; Vitamin K; Vitamin K Deficiency

Topics: Birth Weight; Blood Coagulation Disorders; Blood Coagulation Tests; Cerebral Hemorrhage; Gestational Age; Humans; Infant Mortality; Infant, Newborn; Infant, Newborn, Diseases; Vitamin K

Topics: Bilirubin; Birth Weight; Blood Proteins; Female; Hemoglobinometry; Hemoglobins; Humans; Infant, Newborn; Maternal-Fetal Exchange; Pregnancy; Prothrombin; Umbilical Cord; Vitamin K

Topics: Birth Weight; Ethnology; Humans; Infant; Infant Mortality; Infant Nutritional Physiological Phenomena; Infant, Newborn; Infant, Premature; Prognosis; Sex; Twins; Vitamin K

Topics: Birth Weight; Humans; Infant, Newborn; Prothrombin; Vitamin K; Vitamin K Deficiency Bleeding